Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients.

× No keyword cloud information.

5 in total

1. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Authors: Robert E Ariano; Daniel S Sitar; Sheryl A Zelenitsky; Ryan Zarychanski; Amarnath Pisipati; Stéphane Ahern; Salmaan Kanji; Jordi Rello; Anand Kumar
Journal: CMAJ Date: 2010-02-16 Impact factor: 8.262

2. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

Authors: Hui-Ling Yen; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal: J Infect Dis Date: 2005-07-15 Impact factor: 5.226

3. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: Anthony E Fiore; Alicia Fry; David Shay; Larisa Gubareva; Joseph S Bresee; Timothy M Uyeki
Journal: MMWR Recomm Rep Date: 2011-01-21

4. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.

Authors: N Lee; D S C Hui; Z Zuo; K L K Ngai; G C Y Lui; S K Wo; W W S Tam; M C W Chan; B C K Wong; R Y K Wong; K W Choi; W W Y Sin; E L Y Lee; B Tomlinson; F G Hayden; P K S Chan
Journal: Clin Infect Dis Date: 2013-09-17 Impact factor: 9.079

5. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial.

Authors:
Journal: BMJ Date: 2013-05-30

5 in total

7 in total

1. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors: Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal: Clin Infect Dis Date: 2019-03-05 Impact factor: 9.079

2. Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.

Authors: Ching-Tai Huang; Chen-Yiu Hung; Tse-Ching Chen; Chun-Yen Lin; Yung-Chang Lin; Chia-Shiang Chang; Yueh-Chia He; Yu-Lin Huang; Avijit Dutta
Journal: Sci Rep Date: 2017-06-23 Impact factor: 4.379

Review 3. Contemporary management of severe influenza disease in the intensive care unit.

Authors: Patrick M Wieruszewski; Dustin D Linn
Journal: J Crit Care Date: 2018-08-20 Impact factor: 3.425

4. Alternative Regimens of Neuraminidase Inhibitors for Therapy of Hospitalized Adults with Influenza: A Systematic Review of Randomized Controlled Trials.

Authors: Sofia Tejada; Laura Campogiani; Candela Solé-Lleonart; Jordi Rello
Journal: Adv Ther Date: 2020-04-28 Impact factor: 3.845

Review 5. Update in Viral Infections in the Intensive Care Unit.

Authors: Paraskevi C Fragkou; Charalampos D Moschopoulos; Emmanouil Karofylakis; Theodoros Kelesidis; Sotirios Tsiodras
Journal: Front Med (Lausanne) Date: 2021-02-23

6. [Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu].

Authors: J Poissy; O Terrier; B Lina; J Textoris; M Rosa-Calatrava
Journal: Reanimation Date: 2016-04-07

Review 7. Critical care management of adults with community-acquired severe respiratory viral infection.

Authors: Yaseen M Arabi; Robert Fowler; Frederick G Hayden
Journal: Intensive Care Med Date: 2020-02-10 Impact factor: 17.440

7 in total